BSHRI discovers new evidence in Alzheimer’s disease research

Friday, May 13, 2011 11:46 AM

Researchers at Banner Sun Health Research Institute (BSHRI) have found further evidence linking copper to the increased probability of developing Alzheimer's disease, according to a recent study published in the International Journal of Alzheimer's Disease

The study, led by BSHRI researcher Dr. Larry Sparks, employed a cholesterol-fed model of Alzheimer's disease to investigate the relationship between Alzheimer's disease-like neurofibrillary tangle (NFT) neuropathology and tau protein levels as the main component of NFT.

Researchers measured brain and plasma tau levels and semi-quantified NFT-like neuropathology in cholesterol-fed rabbits administered drinking water of varying quality (distilled, tap and distilled with copper) compared to animals receiving normal food and local tap water.

"Total tau levels in plasma were increased in all cholesterol-fed rabbits compared to animals on normal chow, regardless of quality of water," said Sparks. "These studies suggest the possibility that circulating tau could be the source of the tau accumulating in the brain."

Previously, copper has been implicated in the progression and possibly the cause of Alzheimer's disease as studies have shown the that increased copper intake significantly increases the rate of progression of Alzheimer's disease in the setting of elevated fat intake.

In the BSHRI study, Sparks and his team performed a pilot study of long-term dietary cholesterol in four groups of rabbits. One group was administered normal food and water and three groups were administered increasing levels of a cholesterol diet for five months. Significantly, plasma levels of tau increased by 40 to 50 percent in each of the cholesterol-fed animal groups after five months of the experimental diet.

"This is the first study of the effect of intake of copper or trace metals on levels of the protein tau in the blood and brain," Sparks added. "We have shown that there is increased tau neuropathology associated with increasing levels of tau in the blood and brain of the cholesterol-fed rabbit."

 

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs